Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Circulation Research
|
July 17, 2020
Mineralocorticoid Receptors: Master Regulators of Extracellular Matrix Remodeling
Achim Lother
Kidney International Supplements
|
May 9, 2022
Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms
Johann Bauersachs, Achim Lother
Frontiers in Cardiovascular Medicine
|
February 16, 2023
Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
Argen Mamazhakypov, Achim Lother
Steroids
|
August 9, 2023
Molecular pharmacology of mineralocorticoid receptor antagonists: The role of co-regulators
Duygu Koca, Achim Lother
Basic Research in Cardiology
|
July 26, 2023
The heterocellular heart: identities, interactions, and implications for cardiology
Achim Lother, Peter Kohl
Pharmacology & Therapeutics
|
July 27, 2016
Pharmacology of heart failure: From basic science to novel therapies
Achim Lother, Lutz Hein
Hypertension (Dallas, Tex. : 1979)
|
May 25, 2016
Vascular Mineralocorticoid Receptors: Linking Risk Factors, Hypertension, and Heart Disease
Achim Lother, Lutz Hein
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 7, 2025
Inotropes and mortality in patients with cardiogenic shock: more questions than answers
Achim Lother, Dawid L Staudacher
Circulation
|
September 13, 2021
Letter by Lother et al Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes"
Achim Lother, Christoph Bode, Lutz Hein
Pharmacology & Therapeutics
|
September 4, 2021
Mineralocorticoid receptors in pulmonary hypertension and right heart failure: From molecular biology to therapeutic targeting
Argen Mamazhakypov, Lutz Hein, Achim Lother
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Circulation Research
|
July 17, 2020
Mineralocorticoid Receptors: Master Regulators of Extracellular Matrix Remodeling
Achim Lother
Kidney International Supplements
|
May 9, 2022
Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms
Johann Bauersachs, Achim Lother
Frontiers in Cardiovascular Medicine
|
February 16, 2023
Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
Argen Mamazhakypov, Achim Lother
Steroids
|
August 9, 2023
Molecular pharmacology of mineralocorticoid receptor antagonists: The role of co-regulators
Duygu Koca, Achim Lother
Basic Research in Cardiology
|
July 26, 2023
The heterocellular heart: identities, interactions, and implications for cardiology
Achim Lother, Peter Kohl
Pharmacology & Therapeutics
|
July 27, 2016
Pharmacology of heart failure: From basic science to novel therapies
Achim Lother, Lutz Hein
Hypertension (Dallas, Tex. : 1979)
|
May 25, 2016
Vascular Mineralocorticoid Receptors: Linking Risk Factors, Hypertension, and Heart Disease
Achim Lother, Lutz Hein
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 7, 2025
Inotropes and mortality in patients with cardiogenic shock: more questions than answers
Achim Lother, Dawid L Staudacher
Circulation
|
September 13, 2021
Letter by Lother et al Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes"
Achim Lother, Christoph Bode, Lutz Hein
Pharmacology & Therapeutics
|
September 4, 2021
Mineralocorticoid receptors in pulmonary hypertension and right heart failure: From molecular biology to therapeutic targeting
Argen Mamazhakypov, Lutz Hein, Achim Lother
Page
of 8